Interactions between conserved residues in transmembrane helices 2 and 7 during angiotensin AT1 receptor activation

Chemical Biology and Drug Design

Volumn 68, Issue 5, 2006, Pages 239-249

  Nikiforovich, Gregory V ^a   Zhang, Meng ^b   Yang, Qing ^b   Jagadeesh, Gowraganahalli ^b   Chen, Hao Chia ^b   Hunyady, László ^c   Marshall, Garland R ^a   Catt, Kevin J ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Angiotensin receptor type 1; G protein coupled receptors; Molecular modeling; Site directed mutagenesis

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ASPARAGINE; ASPARTIC ACID; G PROTEIN COUPLED RECEPTOR; INOSITOL PHOSPHATE; MEMBRANE PROTEIN; MUTANT PROTEIN; RADIOLIGAND; SERINE; TRANSMEMBRANE HELIX 2 PROTEIN; TRANSMEMBRANE HELIX 7 PROTEIN; TYROSINE;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; DRUG RECEPTOR BINDING; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SITE DIRECTED MUTAGENESIS;

AMINO ACIDS; ANIMALS; CONSERVED SEQUENCE; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; MUTATION, MISSENSE; PROTEIN STRUCTURE, SECONDARY; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 33845534906     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2006.00444.x     Document Type: Article

References (51)

1. Timmermans P.B.M.W.M., Wong P.C., Chiu A.T., Herblin W.F., Benfield P., Carini D.J., Lee R.J., Wexler R.R., Saye J.A.M., Smith R.D. (1993) Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev;45:205-251.
2. Inagami T. (1999) Molecular biology and signaling of angiotensin receptors: an overview. J Am Soc Nephrol;10 (Suppl. 11):S2-S7.
3. 1 receptor trends. Pharmacol Sci;17:135-140.
4. 1) receptor function. Regul Pept;79:9-23.
5. Hunyady L., Catt K.J. (2006) Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol;20:953-970.
6. Griendling K.K., Lassègue B., Alexander R.W. (1996) Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol;36:281-306.
7. Spät A., Hunyady L. (2004) Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev;84:489-539.
8. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., Miyano M. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science;289:739-745.
9. Teller D.C., Okada T., Behnke C.A., Palczewski K., Stenkamp R.E. (2001) Advances in determination of a high-resoultion three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry;40:7761- 7772.
10. Okada T., Fujiyoshi Y., Silow M., Navarro J., Landau E.M., Shichida Y. (2002) Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proc Natl Acad Sci U S A;99:5982-5987.
11. Li J., Edwards P.C., Burghammer M., Villa C., Schertler G.F. (2004) Structure of bovine rhodopsin in a trigonal crystal form. J Mol Biol;343:1409-1438.
12. Hubbell W.L., Altenbach C., Khorana H.G. (2003) Rhodopsin structure, dynamics and activation. Adv Protein Chem;63:243-290.
13. Nikiforovich G.V., Marshall G.R. (2003) 3D model for meta-II rhodopsin, an activated G-protein-coupled receptor. Biochemistry;42:9110-9120.
14. Ballesteros J.A., Shi L., Javitch J.A. (2001) Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol Pharmacol;60:1-19.
15. 1a angiotensin II receptor is essential for its coupling to phospholipase C. J Biol Chem;269:20815-20818.
16. 1 angiotensin receptor function on adjacent asparagine residues in the seventh transmembrane helix. Mol Pharmacol;54:427-434.
17. Hunyady L., Bor M., Baukal A.J., Balla T., Catt K.J. (1995) Critical role of a conserved intramembrane tyrosine residue in angiotensin II receptor activation. J Biol Chem;270:16602-16609.
18. Laporte S.A., Servant G., Richard D.E., Escher E., Guillemette G., Leduc R. (1996) The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization. Mol Pharmacol;49:89-95.
19. 74 of the rat angiotensin-II receptor confers changes in antagonist affinities and abolishes G-protein coupling. Proc Natl Acad Sci U S A;90:5133-5137.
20. Hunyady L., Baukal A.J., Balla T., Catt K.J. (1994) Independence of type I angiotensin II receptor endocytosis from G protein coupling and signal transduction. J Biol Chem;269:24798-24804.
21. Joseph M.P., Maigret B., Bonnafous J.C., Marie J., Scheraga H.A. (1995) A computer modeling postulated mechanism for angiotensin II receptor activation. J Protein Chem;14:381-398.
22. Inoue Y., Nakamura N., Inagami T. (1997) A review of mutagenesis studies of angiotensin II type 1 receptor, the three-dimensional receptor model in search of the agonist and antagonist binding site and the hypothesis of a receptor activation mechanism. J Hypertens;15:703-714.
23. Nikiforovich G.V., Marshall G.R. (2001) 3D model for TM region of the AT-1 receptor in complex with angiotensin II independently validated by site-directed mutagenesis data. Biochem Biophys Res Commun;286:1204-1211.
24. 1 receptor. J Pept Res;66:236-248.
25. Nikiforovich G.V., Hruby V.J., Prakash O., Gehrig C.A. (1991) Topographical requirements for delta-selective opioid peptides. Biopolymers;31:941-955.
26. Dunfield L.G., Burgess A.W., Scheraga H.A. (1978) Energy parameters in polypeptides: 8. Empirical potential energy algorithm for the conformational analysis of large molecules. J Phys Chem;82:2609-2616.
27. Nemethy G., Pottle M.S., Scheraga H.A. (1983) Energy parameters in polypeptides: 9. Updating of geometrical parameters, nonbonded interactions, and hydrogen bond interactions for the naturally occuring amino acids. J Phys Chem;87:1883-1887.
28. Munson P.J., Rodbard D. (1980) Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem;107:220-239.
29. Donnelly D., Maudsley S., Gent J.P., Moser R.N., Hurrell C.R., Findlay J.B. (1999) Conserved polar residues in the transmembrane domain of the human tachykinin NK2 receptor: functional roles and structural implications. Biochem J;339:55-61.
30. Sealfon S.C., Chi L., Ebersole B.J., Rodic V., Zhang D., Ballesteros J.A., Weinstein H. (1995) Related contribution of specific helix 2 and 7 residues to conformational activation of the serotonin 5-HT2A receptor. J Biol Chem;270:16683-16688.
31. Perlman J.H., Colson A.O., Wang W., Bence K., Osman R., Gershengorn M.C. (1997) Interactions between conserved residues in transmembrane helices 1, 2, and 7 of the thyrotropin-releasing hormone receptor. J Biol Chem;272:11937- 11942.
32. Zhou W., Flanagan C., Ballesteros J.A., Konvicka K., Davidson J.S., Weinstein H., Millar R.P., Sealfon S.C. (1994) A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. Mol Pharmacol;45:165-170.
33. Cook J.V., Faccenda E., Anderson L., Couper G.G., Eidne K.A., Taylor P.L. (1993) Effects of Asn87 and Asp318 mutations on ligand binding and signal transduction in the rat GnRH receptor. J Endocrinol;139:R1-4.
34. 111. Biochemistry;37:15791- 15798.
35. 1 receptor activation is dependent upon two juxtaposed asparagine residues on transmembrane helices III and VII. J Biol Chem;272:4245-4251.
36. 1 receptor is essential for full agonism. J Biol Chem;270:12846- 12850.
37. 1 receptor in agonist activation. J Biol Chem;270:28511-28514.
38. Noda K., Saad Y., Kinoshita A., Boyle T.P., Graham R.M., Husain A., Karnik S.S. (1995) Tetrazole and carboxylate groups of angiotensin receptor antagonists bind to the same subsite by different mechanisms. J Biol Chem;270:2284-2289.
39. 1 receptor as a ligand contact point: receptor-bound angiotensin II adopts an extended structure. Biochemistry;39:9662-9670.
40. Deraet M., Rihakova L., Boucard A., Perodin J., Sauve S., Mathieu A.P., Guillemette G., Leduc R., Lavigne P., Escher E. (2002) Angiotensin II is bound to both receptors AT1 and AT2,'parallel to the transmembrane domains and in an extended form. Can J Physiol Pharmacol;80:418-425.
41. Clement M., Martin S.S., Beaulieu M.E., Chamberland C., Lavigne P., Leduc R., Guillemette G., Escher E. (2005) Determining the environment of the ligand binding pocket of the human angiotensin'II type I (hAT1) receptor using the methionine proximity assay. J Biol Chem;280:27121-27129.
42. Perodin J., Deraet M., Auger-Messier M., Boucard A.A., Rihakova L., Beaulieu M.E., Lavigne P., Parent J.L., Guillemette G., Leduc R., Escher E. (2002) Residues 293 and 294 are ligand contact points of the human angiotensin type 1 receptor. Biochemistry;41:14348-14356.
43. Nikiforovich G.V., Kao J.L.-F., Plucinska K., Zhang W.J., Marshall G.R. (1994) Conformational analysis of two cyclic analogs of angiotensin: implications for the biologically active conformation. Biochemistry;33:3591- 3598.
44. The model developed by Dr Laerte Oliveira. Available at: http://www.gpcr.org/7tm/models/oliveira/index.html.
45. 1 receptor and the ligand-binding site. J Mol Model;12:325-337.
46. Ward W.H., Timms D., Fersht A.R. (1990) Protein engineering and the study of structure-function relationships in receptors. Trends Pharmacol Sci;11:280-284.
47. Miura S., Karnik S.S. (2002) Constitutive activation of angiotensin II type 1 receptor alters the orientation of transmembrane helix-2. J Biol Chem;277:24299-24305.
48. Miura S., Zhang J., Boros J., Karnik S.S. (2003) TM2-TM7 interaction in coupling movement of transmembrane helices to activation of the angiotensin II type-1 receptor. J Biol Chem;278:3720-3725.
49. Boucard A.A., Roy M., Beaulieu M.E., Lavigne P., Escher E., Guillemette G., Leduc R. (2003) Constitutive activation of the angiotensin II type 1 receptor alters the spatial proximity of transmembrane 7 to the ligand-binding pocket. J Biol Chem;278:36628-36636.
50. Martin S.S., Boucard A.A., Clement M., Escher E., Leduc R., Guillemette G. (2004) Analysis of the third transmembrane domain of the human type 1 angiotensin II receptor by cysteine scanning mutagenesis. J Biol Chem;279:51415-51423.
51. Urizar E., Claeysen S., Deupi X., Govaerts C., Costagliola S., Vassart G., Pardo L. (2005) An activation switch in the rhodopsin family of G protein-coupled receptors: the thyrotropin receptor. J Biol Chem;280:17135- 17141.